SI0670310T1 - Bisulfite adducts of arginine aldehydes useful as thrombin inhibitors and as anticoagulants - Google Patents
Bisulfite adducts of arginine aldehydes useful as thrombin inhibitors and as anticoagulantsInfo
- Publication number
- SI0670310T1 SI0670310T1 SI9530171T SI9530171T SI0670310T1 SI 0670310 T1 SI0670310 T1 SI 0670310T1 SI 9530171 T SI9530171 T SI 9530171T SI 9530171 T SI9530171 T SI 9530171T SI 0670310 T1 SI0670310 T1 SI 0670310T1
- Authority
- SI
- Slovenia
- Prior art keywords
- anticoagulants
- thrombin inhibitors
- bisulfite adducts
- aldehydes useful
- adducts
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06139—Dipeptides with the first amino acid being heterocyclic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
- C07K5/0202—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-X-X-C(=0)-, X being an optionally substituted carbon atom or a heteroatom, e.g. beta-amino acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
- C07K5/0205—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-(X)3-C(=0)-, e.g. statine or derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06078—Dipeptides with the first amino acid being neutral and aromatic or cycloaliphatic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06139—Dipeptides with the first amino acid being heterocyclic
- C07K5/06165—Dipeptides with the first amino acid being heterocyclic and Pro-amino acid; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0821—Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Crystallography & Structural Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Diabetes (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Hematology (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Peptides Or Proteins (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/206,579 US5436229A (en) | 1994-03-04 | 1994-03-04 | Bisulfite adducts of arginine aldehydes |
EP95301389A EP0670310B1 (en) | 1994-03-04 | 1995-03-03 | Bisulfite adducts of arginine aldehydes useful as thrombin inhibitors and as anticoagulants |
Publications (1)
Publication Number | Publication Date |
---|---|
SI0670310T1 true SI0670310T1 (en) | 1999-02-28 |
Family
ID=22767010
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SI9530171T SI0670310T1 (en) | 1994-03-04 | 1995-03-03 | Bisulfite adducts of arginine aldehydes useful as thrombin inhibitors and as anticoagulants |
Country Status (9)
Country | Link |
---|---|
US (1) | US5436229A (es) |
EP (1) | EP0670310B1 (es) |
JP (1) | JPH07278095A (es) |
AT (1) | ATE170508T1 (es) |
CA (1) | CA2143532A1 (es) |
DE (1) | DE69504383T2 (es) |
DK (1) | DK0670310T3 (es) |
ES (1) | ES2120132T3 (es) |
SI (1) | SI0670310T1 (es) |
Families Citing this family (39)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5707966A (en) * | 1994-03-04 | 1998-01-13 | Eli Lilly And Company | Antithrombotic agents |
US5705487A (en) * | 1994-03-04 | 1998-01-06 | Eli Lilly And Company | Antithrombotic agents |
US5726159A (en) * | 1994-03-04 | 1998-03-10 | Eli Lilly And Company | Antithrombotic agents |
CA2143533A1 (en) * | 1994-03-04 | 1995-09-05 | Kenneth D. Kurz | Antithrombotic agents |
ZA951618B (en) * | 1994-03-04 | 1996-08-27 | Lilly Co Eli | Antithrombotic agents |
US5885967A (en) * | 1994-03-04 | 1999-03-23 | Eli Lilly And Company | Antithrombotic agents |
US5602101A (en) * | 1994-03-04 | 1997-02-11 | Eli Lilly And Company | Antithrombotic agents |
US5804560A (en) * | 1995-01-06 | 1998-09-08 | Sibia Neurosciences, Inc. | Peptide and peptide analog protease inhibitors |
US5710130A (en) * | 1995-02-27 | 1998-01-20 | Eli Lilly And Company | Antithrombotic agents |
US5914319A (en) * | 1995-02-27 | 1999-06-22 | Eli Lilly And Company | Antithrombotic agents |
CA2238175A1 (en) * | 1995-11-28 | 1997-06-19 | Cephalon, Inc. | D-amino acid derived inhibitors of cysteine and serine proteases |
WO1997019919A1 (fr) * | 1995-11-30 | 1997-06-05 | C & C Research Laboratories | Derives de sulfamides |
US6001994A (en) * | 1995-12-13 | 1999-12-14 | Eli Lilly And Company | Process for making gemcitabine hydrochloride |
US5756775A (en) * | 1995-12-13 | 1998-05-26 | Eli Lilly And Company | Process to make α,α-difluoro-β-hydroxyl thiol esters |
DE69832268T2 (de) | 1997-04-18 | 2006-07-13 | Cephalon, Inc. | Peptidyl2-amino-1hydroxyalkansulfonsäuren als zysteinprotease-inhibitoren |
WO1998051684A1 (en) | 1997-05-15 | 1998-11-19 | Eli Lilly And Company | Antithrombotic compound |
SE9802973D0 (sv) * | 1998-09-03 | 1998-09-03 | Astra Ab | Immediate release tablet |
DE10121003A1 (de) * | 2001-04-28 | 2002-12-19 | Aventis Pharma Gmbh | Anthranilsäureamide, Verfahren zur Herstellung, ihrer Verwendung als Medikament sowie sie enthaltende pharmazeutische Zubereitungen |
JP4230908B2 (ja) * | 2001-08-21 | 2009-02-25 | イヴァックス インスティテュート フォー ドラッグ リサーチ,リミテッド | ペプチド・アルギナル類および播種性血管内血液凝固の治療方法 |
CN107858217B (zh) * | 2011-07-01 | 2021-03-23 | 诺维信公司 | 稳定化的枯草杆菌蛋白酶组合物 |
CN112143570A (zh) | 2011-07-01 | 2020-12-29 | 诺维信公司 | 液体洗涤剂组合物 |
CN105189724A (zh) | 2013-03-14 | 2015-12-23 | 诺维信公司 | 含有酶和抑制剂的水溶性膜 |
JP7020778B2 (ja) | 2013-05-03 | 2022-02-16 | ノボザイムス アクティーゼルスカブ | 洗剤酵素のマイクロカプセル化 |
WO2016001319A1 (en) | 2014-07-03 | 2016-01-07 | Novozymes A/S | Improved stabilization of non-protease enzyme |
WO2016097352A1 (en) | 2014-12-19 | 2016-06-23 | Novozymes A/S | Protease variants and polynucleotides encoding same |
EP3950939A3 (en) | 2015-07-06 | 2022-06-08 | Novozymes A/S | Lipase variants and polynucleotides encoding same |
WO2017061871A1 (en) | 2015-10-09 | 2017-04-13 | Axichem Ab | Bird feed and in particular poultry feed, comprising synthetic capsaicinoid derivatives and such feed for prohylactic use or treatment of salmonella infection |
EP3619304A1 (en) | 2017-05-05 | 2020-03-11 | Novozymes A/S | Compositions comprising lipase and sulfite |
CN111108183A (zh) | 2017-06-30 | 2020-05-05 | 诺维信公司 | 酶浆液组合物 |
EP3704219B1 (en) | 2017-11-01 | 2024-01-10 | Novozymes A/S | Polypeptides and compositions comprising such polypeptides |
EP3704240A1 (en) | 2017-11-01 | 2020-09-09 | Novozymes A/S | Polypeptides and compositions comprising such polypeptides |
CN111770788B (zh) | 2018-03-13 | 2023-07-25 | 诺维信公司 | 使用氨基糖低聚物进行微囊化 |
EP3647397A1 (en) | 2018-10-31 | 2020-05-06 | Henkel AG & Co. KGaA | Cleaning compositions containing dispersins iv |
EP3647398B1 (en) | 2018-10-31 | 2024-05-15 | Henkel AG & Co. KGaA | Cleaning compositions containing dispersins v |
MX2021015894A (es) | 2019-07-01 | 2022-02-03 | Basf Se | Peptidos acetales para estabilizar enzimas. |
US20220411773A1 (en) | 2019-12-20 | 2022-12-29 | Novozymes A/S | Polypeptides having proteolytic activity and use thereof |
WO2021236475A1 (en) * | 2020-05-18 | 2021-11-25 | Asinex Corporation | Compounds that inhibit asparagine synthetase and their methods of use |
WO2022189521A1 (en) | 2021-03-12 | 2022-09-15 | Novozymes A/S | Polypeptide variants |
WO2024131880A2 (en) | 2022-12-23 | 2024-06-27 | Novozymes A/S | Detergent composition comprising catalase and amylase |
Family Cites Families (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
HU177098B (en) * | 1979-01-04 | 1981-07-28 | Gyogyszerkutato Intezet | Process for producing new peptidyl-n-carboxy-l-arginin-a |
HU178398B (en) * | 1979-06-12 | 1982-04-28 | Gyogyszerkutato Intezet | Process for producing new agmatine derivatives of activity against haemagglutination |
HU184368B (en) * | 1981-01-13 | 1984-08-28 | Gyogyszerkutato Intezet | Process for preparing d-phenyl-alanyl-l-propyl-l-arginine-ald ehyde-shulphate |
DE3481913D1 (de) * | 1983-04-27 | 1990-05-17 | Ici America Inc | Prolin-derivate. |
HU192646B (en) * | 1984-12-21 | 1987-06-29 | Gyogyszerkutato Intezet | Process for preparing new n-alkyl-peptide aldehydes |
DE3606480A1 (de) * | 1986-02-28 | 1987-09-03 | Behringwerke Ag | Oligopeptidylnitrilderivate, diese enthaltende mittel, verfahren zu ihrer herstellung und ihre verwendung |
US5187157A (en) * | 1987-06-05 | 1993-02-16 | Du Pont Merck Pharmaceutical Company | Peptide boronic acid inhibitors of trypsin-like proteases |
DE3827415A1 (de) * | 1988-08-12 | 1990-02-15 | Behringwerke Ag | Peptidderivate, verfahren zu ihrer herstellung und ihre verwendung |
US5204323B1 (en) * | 1988-10-06 | 1995-07-18 | Ciba Geigy Corp | Hirudin antidotal compositions and methods |
CA2021660A1 (en) * | 1989-07-26 | 1991-01-27 | Philippe Bey | Peptidase inhibitors |
US5053392A (en) * | 1989-12-01 | 1991-10-01 | Rhone-Poulenc Rorer Pharmaceuticals Inc. | Novel arginine, glycine, aspartic acid derivatives as platelet-aggregation inhibitors |
IL99527A (en) * | 1990-09-28 | 1997-08-14 | Lilly Co Eli | Tripeptide antithrombotic agents |
EP0503203A1 (en) * | 1991-03-15 | 1992-09-16 | Merrell Dow Pharmaceuticals Inc. | Novel thrombin inhibitors |
CA2075154A1 (en) * | 1991-08-06 | 1993-02-07 | Neelakantan Balasubramanian | Peptide aldehydes as antithrombotic agents |
AU655831B2 (en) * | 1991-08-22 | 1995-01-12 | Merrell Pharmaceuticals Inc. | Novel orally-active elastase inhibitors |
SE9102462D0 (sv) * | 1991-08-28 | 1991-08-28 | Astra Ab | New isosteric peptides |
AU2882792A (en) * | 1991-10-23 | 1993-05-21 | Procter & Gamble Company, The | Tripeptide derivative anti-inflammatory agents |
US5250660A (en) * | 1991-11-12 | 1993-10-05 | Eli Lilly And Company | Peptide purification process |
CZ333492A3 (en) * | 1991-11-12 | 1993-09-15 | Lilly Co Eli | Dipeptide of l-azetidine-2-carboxylic acids and l-argininaldehyde, process of its preparation and pharmaceutical preparation in which said dipeptide is comprised |
-
1994
- 1994-03-04 US US08/206,579 patent/US5436229A/en not_active Expired - Fee Related
-
1995
- 1995-02-28 CA CA002143532A patent/CA2143532A1/en not_active Abandoned
- 1995-03-03 JP JP7043919A patent/JPH07278095A/ja not_active Withdrawn
- 1995-03-03 AT AT95301389T patent/ATE170508T1/de not_active IP Right Cessation
- 1995-03-03 SI SI9530171T patent/SI0670310T1/xx unknown
- 1995-03-03 ES ES95301389T patent/ES2120132T3/es not_active Expired - Lifetime
- 1995-03-03 DE DE69504383T patent/DE69504383T2/de not_active Expired - Fee Related
- 1995-03-03 EP EP95301389A patent/EP0670310B1/en not_active Expired - Lifetime
- 1995-03-03 DK DK95301389T patent/DK0670310T3/da active
Also Published As
Publication number | Publication date |
---|---|
DE69504383D1 (de) | 1998-10-08 |
EP0670310A1 (en) | 1995-09-06 |
ES2120132T3 (es) | 1998-10-16 |
EP0670310B1 (en) | 1998-09-02 |
DK0670310T3 (da) | 1999-02-08 |
CA2143532A1 (en) | 1995-09-05 |
ATE170508T1 (de) | 1998-09-15 |
US5436229A (en) | 1995-07-25 |
JPH07278095A (ja) | 1995-10-24 |
DE69504383T2 (de) | 1999-02-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SI0670310T1 (en) | Bisulfite adducts of arginine aldehydes useful as thrombin inhibitors and as anticoagulants | |
DE69507062D1 (de) | Verbindungen zur Hemmung der Thrombin | |
MY119987A (en) | Antithrombotic agents. | |
BR9900443A (pt) | Esteres de ácido aril acrìlico. | |
DE69508192D1 (de) | Wasserlösliches nimesulid-salz, sowie dessen verwendung zur behandlung von entzündungen | |
MY125150A (en) | Factor vlla inhibitors | |
EP0863755A4 (en) | ANTITHROMBOTIC DIAMINES | |
AP2003002915A0 (en) | HIV protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis. | |
ATE251176T1 (de) | Intermediate zur herstellung von thrombininhibitoren als anticoagulantien | |
TR199901191T2 (xx) | Benzamidoaldehitlerin sistein proteaz� inhibit�r� olarak kullan�m�. | |
UA32556C2 (uk) | (1r,4ar,8ar)-1,2,3,4,5,6,7,8-пергідроізохінолін-1- карбоніл-(l)-пролініл- (l)-аргінін альдегід для використання як антитромбового препарату і фармацевтична композиція на його основі | |
DK0976722T3 (da) | Benzamidin-derivater | |
TR199900310T2 (xx) | Trombin inhibit�rleri | |
PT1206484E (pt) | Compostos e composicoes antipicornavirais, suas utilizacoes farmaceuticas e materiais para a sua sintese | |
DE60137069D1 (de) | Arzneizusammensetzungen enthaltend modafinilverbindungen | |
WO2001079167A3 (en) | Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis | |
BR9904075A (pt) | Cetonas | |
GB0007239D0 (en) | Use | |
WO2001096297A3 (en) | Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis | |
TH19715A (th) | สารยับยั้งโลหิตจับตัวเป็นก้อน |